Maarten H Geurts - JoVE Visualize

Showing results (1-10 of 25) with videos related to

Pageof 3

Sort By:

Stem Cell Reports|March 10, 2021

The Organoid Platform: Promises and Challenges as Tools in the Fight against COVID-19Maarten H Geurts, Jelte van der Vaart, Joep Beumer, et al.

Journal of Visualized Experiments : Jove|February 22, 2023

Establishment, Maintenance, Differentiation, Genetic Manipulation, and Transplantation of Mouse and Human Lacrimal Gland OrganoidsMarie Bannier-Hélaouët, Maarten H Geurts, Jeroen Korving, et al.

STAR Protocols|July 14, 2024

Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR toolsMartina Celotti, Lucca L M Derks, Johan van Es, et al.

STAR Protocols|August 31, 2022

Differentiation and CRISPR-Cas9-mediated genetic engineering of human intestinal organoidsAdriana Martinez-Silgado, Fjodor A Yousef Yengej, Jens Puschhof, et al.

Nature|March 8, 2018

Evolved Cas9 variants with broad PAM compatibility and high DNA specificityJohnny H Hu, Shannon M Miller, Maarten H Geurts, et al.

Nature Cancer|November 2, 2024

Recapitulating the adenoma-carcinoma sequence by selection of four spontaneous oncogenic mutations in mismatch-repair-deficient human colon organoidsTomohiro Mizutani, Matteo Boretto, Sangho Lim, et al.

Life Science Alliance|August 10, 2021

Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoidsMaarten H Geurts, Eyleen de Poel, Cayetano Pleguezuelos-Manzano, et al.

Journal of the National Cancer Institute|October 8, 2019

Modeling Breast Cancer Using CRISPR-Cas9-Mediated Engineering of Human Breast OrganoidsJohanna F Dekkers, James R Whittle, François Vaillant, et al.

Nature Biotechnology|February 24, 2023

Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosisDelilah Hendriks, Jos F Brouwers, Karien Hamer, et al.

Journal of Virology|August 9, 2023

SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid modelsAnna Z Mykytyn, Tim I Breugem, Maarten H Geurts, et al.

Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:

Pageof 3

Stem Cell Reports|March 10, 2021

The Organoid Platform: Promises and Challenges as Tools in the Fight against COVID-19Maarten H Geurts, Jelte van der Vaart, Joep Beumer, et al.

Journal of Visualized Experiments : Jove|February 22, 2023

Establishment, Maintenance, Differentiation, Genetic Manipulation, and Transplantation of Mouse and Human Lacrimal Gland OrganoidsMarie Bannier-Hélaouët, Maarten H Geurts, Jeroen Korving, et al.

STAR Protocols|July 14, 2024

Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR toolsMartina Celotti, Lucca L M Derks, Johan van Es, et al.

STAR Protocols|August 31, 2022

Differentiation and CRISPR-Cas9-mediated genetic engineering of human intestinal organoidsAdriana Martinez-Silgado, Fjodor A Yousef Yengej, Jens Puschhof, et al.

Nature|March 8, 2018

Evolved Cas9 variants with broad PAM compatibility and high DNA specificityJohnny H Hu, Shannon M Miller, Maarten H Geurts, et al.

Nature Cancer|November 2, 2024

Recapitulating the adenoma-carcinoma sequence by selection of four spontaneous oncogenic mutations in mismatch-repair-deficient human colon organoidsTomohiro Mizutani, Matteo Boretto, Sangho Lim, et al.

Life Science Alliance|August 10, 2021

Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoidsMaarten H Geurts, Eyleen de Poel, Cayetano Pleguezuelos-Manzano, et al.

Journal of the National Cancer Institute|October 8, 2019

Modeling Breast Cancer Using CRISPR-Cas9-Mediated Engineering of Human Breast OrganoidsJohanna F Dekkers, James R Whittle, François Vaillant, et al.

Nature Biotechnology|February 24, 2023

Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosisDelilah Hendriks, Jos F Brouwers, Karien Hamer, et al.

Journal of Virology|August 9, 2023

SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid modelsAnna Z Mykytyn, Tim I Breugem, Maarten H Geurts, et al.

Pageof 3